MPC-3100

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2015
01220112015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Various types of Hsp90 inhibitors have been and continue to undergo clinical investigation. One development candidate is the… (More)
Is this relevant?
2012
2012
Modulation of Hsp90 (heat shock protein 90) function has been recognized as an attractive approach for cancer treatment, since… (More)
Is this relevant?
2011
2011
e13016 Background: MPC-3100, an orally bioavailable synthetic inhibitor of HSP90, has demonstrated efficacy in animal models and… (More)
Is this relevant?
2011
2011
e13019 Background: MPC-3100 is an oral synthetic inhibitor of HSP90, in a phase I safety study in cancer patients. Major… (More)
Is this relevant?